Top 10 Companies in the (S)-a‑chloropropionic acid (CAS 29617‑66‑1) Market (2026): Market Leaders Driving Global Specialty Chemical Supply

In Business Insights
July 26, 2026

MARKET INSIGHTS

Global (S)-α‑chloropropionic acid (CAS 29617‑66‑1) market size was valued at USD 78.4 million in 2025. The market is projected to rise from USD 82.6 million in 2026 to USD 134.2 million by 2034, indicating a CAGR of 6.2 % over the forecast period.

(S)-α‑chloropropionic acid is a chiral halogenated carboxylic acid characterized by a single enantiomeric configuration, making it an essential building block in asymmetric synthesis. The compound serves as a key intermediate for the production of herbicides, pharmaceuticals, and specialty agrochemicals, especially where stereochemical precision is critical.

Demand momentum is driven by the expanding need for enantiopure intermediates in pharmaceutical manufacturing and the agrochemical sector’s preference for chirally pure active ingredients. Rising investment in fine chemicals and the adoption of green chemistry principles reinforce the demand for high‑purity (S)-α‑chloropropionic acid across global supply chains. Leading producers include Nanjing Chemlin Chemical Industry Co., Ltd., Yancheng Longsheng Chemical, and other fine‑chemical manufacturers with established chiral synthesis capabilities.

(S)-a‑chloropropionic acid (CAS 29617‑66‑1) Market – View in Detailed Research Report

Top 10 Companies in the Market

  1. Hairui Industries Co., Ltd.

    Headquarters: China

    Key Offering: Pharmaceutical‑grade (S)-α‑chloropropionic acid with >99 % ee

    Hairui Industries leverages an integrated production line that couples asymmetric chlorination with inline chiral resolution, ensuring consistent optical purity for API developers. The company’s ISO‑9001 certification and robust quality management system satisfy the stringent demands of global pharmaceutical buyers.

    Sustainability/ Growth Initiatives: Investment in energy‑efficient reactors and waste‑minimization protocols reduces the carbon footprint of each kilogram produced.

    • ISO‑9001, ISO‑14001 compliance
    • Dedicated R&D for continuous‑flow synthesis
    • Partnerships with academic institutions for biocatalytic route development
  2. Capot Chemical Co., Ltd.

    Headquarters: China

    Key Offering: Industrial‑grade (S)-α‑chloropropionic acid for agrochemical intermediates

    Capot’s production facilities are located in the Jiangsu province, where proximity to raw‑material suppliers and logistics hubs reduces lead time for large‑volume orders. The firm’s emphasis on process scalability supports its position as a preferred supplier for herbicide manufacturers.

    Sustainability/ Growth Initiatives: Implementation of closed‑loop solvent recovery and real‑time process monitoring to lower operational costs.

    • Advanced solvent‑recycling system
    • Real‑time process analytics
    • Strategic alliances with herbicide OEMs
  3. Finetech Industry Limited

    Headquarters: China

    Key Offering: Custom‑synthesis of (S)-α‑chloropropionic acid for niche pharmaceutical applications

    Finetech differentiates itself through flexible contract manufacturing, offering tailored optical purities and rapid turnaround for research laboratories and CDMO clients.

    Sustainability/ Growth Initiatives: Adoption of green‑chemistry protocols, including aqueous‑phase reactions and minimal‑solvent approaches.

    • Aqueous‑phase synthesis
    • Rapid scale‑up capabilities
    • Client‑centric quality assurance
  4. Qingdao Zkht Chemical Co., Ltd.

    Headquarters: China

    Key Offering: High‑purity (S)-α‑chloropropionic acid with >99 % ee for API development

    Qingdao Zkht’s investment in chiral resolution technologies and enzyme‑catalysed routes has positioned it as a leader in delivering low‑cost, high‑quality chiral intermediates.

    Sustainability/ Growth Initiatives: Biocatalytic processes that reduce hazardous reagent use.

    • Enzyme‑based resolution
    • Process‑intensification studies
    • Collaboration with European R&D hubs
  5. Shanghai Trustin Chemical Co., Ltd.

    Headquarters: China

    Key Offering: Technical‑grade (S)-α‑chloropropionic acid for specialty chemical synthesis

    Shanghai Trustin serves a diverse portfolio of fine‑chemical clients, offering customizable purity levels and packaging options.

    Sustainability/ Growth Initiatives: Implementation of digital twin technology for process optimization.

    • Digital process control
    • Flexible contract manufacturing
    • Enhanced supply‑chain transparency
  6. Achieve Chemicals Co., Ltd.

    Headquarters: China

    Key Offering: High‑purity (S)-α‑chloropropionic acid for agrochemical intermediates

    Achieve Chemicals focuses on supporting precision‑herbicide development through rapid delivery of enantiopure intermediates.

    Sustainability/ Growth Initiatives: Adoption of renewable feedstocks for raw‑material sourcing.

    • Renewable‑feedstock utilization
    • Eco‑friendly packaging solutions
    • Collaborations with green‑chemistry consortia
  7. Beijing Mesochem Technology Co., Ltd.

    Headquarters: China

    Key Offering: Enzymatically resolved (S)-α‑chloropropionic acid for pharmaceutical intermediates

    Beijing Mesochem’s proprietary halohydrin dehalogenase platform delivers high‑enantioselectivity under mild conditions, appealing to cost‑sensitive pharma clients.

    Sustainability/ Growth Initiatives: Integration of life‑cycle assessment into product development.

    • Life‑cycle assessment (LCA) integration
    • Biocatalytic process development
    • Strategic alliances with biotech firms
  8. Hunan Aslsen Chemicals Co., Ltd.

    Headquarters: China

    Key Offering: Industrial‑grade (S)-α‑chloropropionic acid for large‑scale agrochemical production

    Hunan Aslsen’s production capacity is tailored to meet the high‑volume demands of agrochemical OEMs, with a focus on cost efficiency.

    Sustainability/ Growth Initiatives: Implementation of solvent‑recycling units and waste‑reduction strategies.

    • Solvent‑recycling infrastructure
    • Waste‑minimization protocols
    • Process‑scale optimization
  9. Ningbo Inno Pharmchem Co., Ltd.

    Headquarters: China

    Key Offering: Custom synthesis of (S)-α‑chloropropionic acid for specialty pharmaceuticals

    Ningbo Inno Pharmchem offers a rapid‑turnaround service for small‑batch, high‑purity chiral intermediates, catering to early‑stage drug discovery.

    Sustainability/ Growth Initiatives: Focus on green‑chemistry pathways and reduced solvent usage.

    • Aqueous‑phase synthesis
    • Rapid scale‑up capabilities
    • Client‑centric quality assurance
  10. Kingch Chemicals

    Headquarters: China

    Key Offering: High‑purity (S)-α‑chloropropionic acid for pharmaceutical intermediates

    Kingch’s strategic focus on quality and regulatory compliance makes it a trusted partner for API developers seeking consistent enantiomeric excess.

    Sustainability/ Growth Initiatives: Adoption of renewable energy sources for manufacturing operations.

    • Renewable energy integration
    • Advanced process controls
    • Collaborations with regulatory bodies

Download FREE Sample Report: (S)-a‑chloropropionic acid (CAS 29617‑66‑1) Market – View in Detailed Research Report

Get Full Report Here: (S)-a‑chloropropionic acid (CAS 29617‑66‑1) Market – View in Detailed Research Report

Outlook: The Future of (S)-a‑chloropropionic acid Market

The trajectory of the market is set by the continued emphasis on single‑enantiomer drugs and precision agrochemicals. Manufacturers that can deliver high‑purity intermediates through cost‑effective, scalable routes—particularly those leveraging biocatalysis or continuous flow chemistry—are likely to capture the majority of growth. Regulatory momentum in both pharmaceutical and agrochemical sectors will sustain demand for chiral intermediates, while sustainability credentials will differentiate leading suppliers.

Key Trends Shaping the Market

  • Adoption of green‑chemistry protocols that reduce hazardous reagent use.
  • Expansion of biocatalytic routes offering high enantioselectivity under mild conditions.
  • Integration of digital process control and real‑time analytics to improve yield and reduce waste.
  • Increasing collaboration between fine‑chemical producers and R&D hubs to accelerate new‑product development.
  • Growth of contract‑manufacturing models that provide flexible, high‑quality chiral intermediates for emerging drug candidates.